Stocks on the Move: Delta, CVS, Nike Premarket
Pre-market trading is buzzing with activity today, with several notable stocks making headlines. Here's a look at some of the movers and shakers to keep an eye on:
Delta Air Lines (DAL): Shares of Delta Air Lines are surging in pre-market trading after the airline reported strong earnings for the second quarter. Revenue beat estimates, and the company raised its full-year revenue forecast. The positive news comes amidst the backdrop of a robust travel recovery, with airlines benefiting from pent-up demand.
CVS Health (CVS): CVS Health stock is trading lower in pre-market after the pharmacy giant missed earnings estimates for the second quarter. The company cited lower prescription drug sales and increased expenses as contributing factors. While revenue slightly exceeded expectations, the earnings miss has dampened investor sentiment.
Nike (NKE): Nike shares are also trading lower in pre-market following the company's second-quarter earnings report. While revenue beat estimates, the company's profit fell short due to higher expenses and promotional discounts. The sportswear giant has been facing pressures from inflation and supply chain disruptions, which are impacting its margins.
What to Watch For:
- Delta's earnings report: Investors will be closely watching Delta's full-year outlook and guidance on future fuel costs.
- CVS's prescription drug sales: Investors will be monitoring the company's ability to navigate changing prescription drug trends and potential cost pressures.
- Nike's sales growth: Investors will be looking for signs of improved sales growth in the second half of the year, as the company battles inflation and supply chain challenges.
The Bottom Line:
Pre-market trading is reflecting a mixed picture for these three major companies. While Delta is riding high on strong earnings, CVS and Nike are facing challenges due to various economic pressures. Investors will be closely watching these stocks throughout the day, looking for further insights into their performance and future prospects.
